wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38626236-2B80F5CB-2ED2-4A30-BD9F-459952AE10DA
Q38626236-2B80F5CB-2ED2-4A30-BD9F-459952AE10DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38626236-2B80F5CB-2ED2-4A30-BD9F-459952AE10DA
The impact of persistence with mirabegron usage versus switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States.
P2860
Q38626236-2B80F5CB-2ED2-4A30-BD9F-459952AE10DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38626236-2B80F5CB-2ED2-4A30-BD9F-459952AE10DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0acf7092256c1eba473534704f185736d5de215
P2860
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada